Article: CSO Danny Galbraith, PhD shares his insights with Drug Target Review.
Webinar: Antibody Drug Conjugates Overcoming Analytical Challenges in Next Gen Cancer Therapies 22
Solvias Earns Strong First Assessment from EcoVadis
Center of Excellence for Biologics and Cell & Gene Therapy opens in Research Triangle Park (RTP), North Carolina.
mAb and ADC Offerings
The Risk of Nitrosamine Impurities in Biologics: What Biopharma Developers Need to Know
Deep CMC testing expertise across
the pharmaceutical spectrum
One partner for your entire
drug development journey
Let’s advance your development project
175
+
PhD-level scientists
800
+
team members in Europe & U.S.
700
+
customers worldwide
19
of the top 20 pharma companies choose Solvias
